Categories AlphaGraphs, Earnings, Health Care

BSX Infographic: Highlights of Boston Scientific’s Q4 2022 earnings report

Medical device maker Boston Scientific Corporation (NYSE: BSX) has announced financial results for the fourth quarter of 2022, reporting a decline in adjusted profit and a modest increase in sales.

In the fourth quarter, net sales increased 4% year-over-year to $3.2 billion, with both operating segments registering growth.

The company’s reported profit more than doubled to $126 million or $0.09 per share during the three-month period from $80 million or $0.06 per share a year earlier. Adjusted earnings advanced 35% annually to $0.45 per share in the fourth quarter.

“Our global team continues living our mission to transform lives, and I’m proud of the results we achieved in the fourth quarter and throughout 2022. In the year ahead we remain committed to our goals of delivering new, meaningful innovations to benefit patients globally while continuing to deliver differentiated financial performance,” said CEO Mike Mahoney.

Most Popular

Important takeaways from Broadcom’s (AVGO) Q4 2023 earnings

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) ended fiscal 2023 on a positive note, delivering strong results for the fourth quarter. In the new fiscal year, the company’s focus will be

Here’s what Signet Jewelers (SIG) expects for the holiday season and beyond

Shares of Signet Jewelers Limited (NYSE: SIG) were down over 2% on Friday. The stock has gained 40% year-to-date and 27% over the past three months. The jewelry retailer saw

DOCU Earnings: DocuSign Q3 2024 revenue up 9%; profit beats estimates

eSignature service provider DocuSign, Inc. (NASDAQ: DOCU) reported higher revenues and better-than-expected adjusted earnings for the third quarter of 2024. The company also provided guidance for the fourth quarter and

Add Comment
Viewing Highlight